Understanding the Concept:
Under Section 17 of the Drugs and Cosmetics Act, 1940, legal definitions categorize substandard pharmaceutical items into three distinct legal groups to protect public health:
• Misbranded Drug (Section 17): Focuses primarily on deceptive appearance, faulty labeling, coloring, or design. A drug is misbranded if it is colored, coated, powdered, or polished to conceal damage, or if its label fails to carry the required medical statements or layout details.
• Adulterated Drug (Section 17A): Focuses on contamination, decomposition, or insanitary preparation environments.
• Spurious Drug (Section 17B): Focuses on deliberate substitution, counterfeiting, or imitation of another brand name/manufacturer.
Step 1: Match definitions to the corresponding options.
* Option A describes an adulterated or spurious action depending on intent.
* Option B states "If it is not labelled in the prescribed manner." This matches the statutory definition of a Misbranded drug under Section 17.
* Option C describes a counterfeit layout, which falls under the legal definition of a Spurious drug.
* Option D describes a product manufactured under filth or unsanitary conditions, which falls under the legal definition of an Adulterated drug.